Systematic Design of a Targeted Organometallic Antitumour Drug in Pre-clinical Development

Author： Dyson Paul J.  

Publisher： Swiss Chemical Society

ISSN： 0009-4293

Source： CHIMIA International Journal for Chemistry, Vol.61, Iss.11, 2007-11, pp. : 698-703

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Homochiral Drug Design and Development by Racemization

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 10, Iss. 5, 2007-06 ,pp. : 326-335

Bentham Science Publishers

Access to resources Recommend Favorite

Virtual Screening in Drug Design and Development

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 13, Iss. 5, 2010-06 ,pp. : 442-453

Bentham Science Publishers

Access to resources Recommend Favorite

The PK‐Eye: A Novel In Vitro Ocular Flow Model for Use in Preclinical Drug Development

By  

JOURNAL OF PHARMACEUTICAL SCIENCES (ELECTRONIC), Vol. 104, Iss. 10, 2015-10 ,pp. : 3330-3342

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic Downstream Development, Optimization and Equipment Design for Biobased Products and Processes

By  

CHEMIE-INGENIEUR-TECHNIK (CIT), Vol. 88, Iss. 9, 2016-09 ,pp. : 1375-1376

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of glutathione‐conjugated asiatic acid‐loaded bovine serum albumin nanoparticles for brain‐targeted drug delivery

By  

JOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Vol. 67, Iss. 11, 2015-11 ,pp. : 1503-1511

John Wiley & Sons Inc

Access to resources Recommend Favorite